www.fdanews.com/articles/82018-praecis-pharmaceuticals-incorporated-stockholders-authorize-reverse-stock-split
PRAECIS PHARMACEUTICALS INCORPORATED STOCKHOLDERS AUTHORIZE REVERSE STOCK SPLIT
October 28, 2005
PRAECIS PHARMACEUTICALS INCORPORATED announced that at the special meeting held today, its stockholders authorized PRAECIS' board of directors to effect a reverse stock split of the Company's common stock. The Company also announced that its board of directors has authorized implementation of a reverse stock split at a ratio of 1-for-5, which the Company expects to take effect after the close of trading on Tuesday, November 1, 2005.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1091179XSL_NEWSML_TO_NEWSML_WEB.xml)